Herbalife Beats Q2 Earnings Expectations, Raises Full-Year Outlook on Back of New Tech and Product Launches

LOS ANGELES – August 6, 2025 – Herbalife Ltd. (HLF) today announced strong second-quarter financial results that surpassed expectations, prompting the global health and wellness company to raise its full-year guidance for 2025. The positive report was bolstered by the launch of major new products and a significant digital transformation initiative, signaling what the company’s CEO calls a “pivotal new era.”

For the second quarter ending June 30, 2025, Herbalife reported an adjusted EBITDA of $173.6 million, exceeding its guidance range. While net sales of $1.3 billion were down a slight 1.7% compared to the same period last year, the figure was flat year-over-year when accounting for significant foreign currency headwinds, meeting the company’s expectations.

The results point to a period of strategic innovation and disciplined execution, with the company raising its full-year 2025 guidance for both net sales and adjusted EBITDA while reducing planned capital expenditures.

“We delivered solid second-quarter results and raised our full-year net sales and adjusted EBITDA guidance,” said CEO Stephan Gratziani. “With the launch of MultiBurn™, the beta unveiling of our AI-assisted Pro2col™ app and the early release of our first healthy lifespan supplement, we’re taking bold steps that reinforce our commitment to innovation, transformative growth and long-term value creation.”

Innovation Drives a “Pivotal New Era”

A key highlight from the quarter was the company’s focus on technology and product innovation. At its North America Extravaganza event in July, Herbalife unveiled the beta version of Pro2col™, a new AI-assisted digital platform for its distributors. Over 7,000 distributors have already joined the early access phase, providing valuable feedback ahead of the commercial launch planned for late 2025.

The company also expanded its product portfolio with two significant launches:

• MultiBurn™: A next-generation weight-loss supplement with clinically studied botanical extracts designed to support metabolic health. The launch positions Herbalife to offer an innovative, non-pharmaceutical option for consumers.

• Healthy Lifespan Supplement: An early release of a new supplement formulated with Niagen®, aimed at the growing healthy aging market.

“Herbalife is entering a pivotal new era,” Gratziani stated, emphasizing the Pro2col™ app as a “bold and powerful first step” in the company’s digital transformation.

Financial Highlights and Outlook

Herbalife demonstrated strong financial discipline, maintaining its total leverage ratio at 3.0x and making progress on its debt reduction strategy.

Q2 2025 Key Financials:

• Net Sales: $1.3 billion

• Net Income: $49.3 million

• Adjusted EBITDA: $173.6 million (exceeding guidance)

• Adjusted Diluted EPS: $0.59

• Net Cash from Operations: $96.0 million

Chief Financial Officer John DeSimone commented, “Net sales were in line with our expectations, while adjusted EBITDA exceeded our expectations. We continue to execute with financial discipline and remain firmly on track to reduce our outstanding debt to $1.4 billion by the end of 2028.”

Looking ahead, the company provided an optimistic outlook for the remainder of the year.

Revised Full-Year 2025 Guidance:

• Net Sales Growth: Revised to (1.0)% to +3.0% (from -2.5% to +2.5%)

• Adjusted EBITDA: Raised to $640 – $660 million (from $625 – $655 million)

• Capital Expenditures: Reduced to $75 – $95 million (from $90 – $120 million)

The company’s focus on distributor engagement continues to yield results, with four of its five regions reporting year-over-year growth in new distributors, led by a 16% increase in Latin America. The combination of financial stability, product innovation, and a clear strategic direction has positioned Herbalife for what it anticipates will be a period of transformative growth.